Source: Benzinga

MannKind: MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference

WESTLAKE VILLAGE, Calif., Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be featured as a presenting company at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 3:30 p.m. (ET) at the Lotte New York Palace ...Full story available on Benzinga.com

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from MannKind's latest SEC filings

Annual Revenue

Based on data from MannKind's latest SEC filings

Employees

Michael Castagna's photo - CEO of MannKind

CEO

Michael Castagna

CEO Approval Rating

62/100

MannKind focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabet... Read more